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Abstract 
Background: The intrinsic physicochemical properties of carbon nanotubes (CNTs) make them unique tools in 
nanotechnology. Their elemental composition, resilience, thermal properties, and surface reactivity make CNTs also 
of undisputed interest in biotechnology. In particular, their extraordinary ability to capture biomolecules on their 
surface makes them essential in this field. The proteins adsorbed on the CNTs create a biological coating that endows 
them the ability to interact with some cell receptors, penetrate membranes or interfere with cell biomechanics, thus 
behaving as an active bio‑camouflage. But some of these proteins unfold, triggering an immune response that unpre‑
dictably changes the biological activity of CNTs. For this reason, the control of the biocorona is fundamental in the 
nanobiotechnology of CNTs.
Results: Using TEM and AFM here we demonstrate a significant increase in CNTs diameter after protein function‑
alization. A quantitative analysis using TGA revealed that between 20 and 60% of the mass of functionalized nano‑
tubes corresponds to protein, with single‑walled CNTs capturing the highest amounts. To qualitatively/quantitatively 
characterize these biocoatings, we studied the biochemical "landscape" of the proteins captured by the different 
nanotubes after functionalization under various conditions. This study revealed a significant variability of the proteins 
in the corona as a function of the type of nanotube, the functionalization temperature, or the time after exposure to 
serum. Remarkably, the functionalization of a single type of CNT with sera from various human donors also resulted in 
different protein landscapes. Given the unpredictable assortment of proteins captured by the corona and the biologi‑
cal implications of this biocoating, we finally designed a method to genetically engineer and produce proteins to 
functionalize nanotubes in a controlled and customizable way.
Conclusions: We demonstrate the high unpredictability of the spontaneous protein corona on CNTs and propose 
a versatile functionalization technique that prevents the binding of nonspecific proteins to the nanotube to improve 
the use of CNTs in biomedical applications.
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Background
Carbon nanotubes (CNTs) represent a highly versatile 
heterogeneous family of uni-dimensional nanomateri-
als that display many extraordinary properties in differ-
ent industrial fields [1, 2]. These carbon-nanofilaments, 
discovered by Iijima in 1991 [3] have held a fundamental 
role in nanotechnology due to their outstanding physi-
cal–chemical behavior that makes CNTs indispensa-
ble for many industrial applications, being some of the 
most promising candidates for the design of multifunc-
tional nanomaterials. More recently, CNTs have been 
incorporated into the biotechnological field driving 
major advances and a large potential impact on medi-
cal developments. Among the CNTs properties, stands 
out one with important implications in biotechnology, 
their high surface reactivity. These nanomaterials have a 
huge surface-to-weight ratio, calculated in ca. 1000  m2/g 
for single-walled CNTs (SWCNTs) and ca. 350  m2/g 
for multi-walled (MWCNTs) (5 walls) [4], a fact that, 
together with the intrinsic reactivity of graphene, makes 
the surface of the CNTs have an enormous capacity to 
interact with their environment and capture all kind of 
molecules from any source. This superficial property of 
CNTs that represents a breakthrough in the fields of drug 
delivery or nanotherapy, can also be a major handicap if 
not properly controlled. In this sense, CNTs can behave 
as Trojan’s vectors introducing undesired chemicals or 
toxins in living organisms [5–7]. But this property makes 
CNTs excellent delivery vectors for transporting many 
different molecules, that do not need to be chemically 
modified for their loading. Among others, CNTs have 
been used to transport doxorubicin [8–10], or 5-fluoro-
uracil [11–14], but also large quantity/variety of biomol-
ecules including nucleic acids [15–17], or proteins [15].
When CNTs are exposed to biological environments, 
they get coated with the surrounding biomolecules, 
mainly proteins, which are active components that signif-
icantly modify the properties of nanotubes in biological 
contexts. Detailed proteomic identification studies have 
documented the promiscuous nature of CNTs where 
more than 750 different human proteins have been iden-
tified on the nanotube corona upon exposure to human 
serum or human cell extracts. Among these, immuno-
globulins, albumin, fibrinogen, and complement are the 
most abundant [17–21]. The implications of the coating 
are pivotal as it provides CNTs with a bio-identity, trans-
forming these nanomaterials into bioactive nanostruc-
tures that can participate or interfere in specific cellular 
functions, often triggering unpredictable interactions. 
For example, albumin on nanotubes triggers receptor-
mediated endocytosis by most cells [22–25], while anti-
body or complement adsorption on their surfaces can 
trigger recognition by phagocytes, and elimination [26].
But CNTs, often taken as a unique nanomaterial, are 
morphologically and chemically diverse, and this is 
important in their interaction with the surrounding bio-
molecules. Previous studies show how the initial binding 
forces implicated in protein adsorption onto CNTs are 
hydrogen bonds [27]. Depending on the nanotube diam-
eter and curvature [28], protein structural changes -such 
as partial unfolding- are also important in the final pro-
tein coating [19, 29]. This way, small nanotube diameters 
of ca. 1–2  nm—in the range size of globular proteins—
have been reported to prompt more structural changes 
in proteins than tubes of smaller or larger diameters [19, 
29]. Furthermore, recent studies show how the degree of 
folding of these corona proteins can significantly trigger 
inflammation, including the production of proinflam-
matory cytokines and innate immune responses [29]. All 
these facts suggest that spontaneous CNT coronas and 
their effects are highly unpredictable, and this could elicit 
completely different cellular and/or organic responses. 
In line with this, the diameter of the nanotube has been 
shown to trigger different biological effects [3, 19, 30–
34]. SWCNTs, for example, preferentially cause DNA 
damage [35, 36], while MWCNTs mainly interfere with 
the cytoskeletal proteins, hindering cellular biomechan-
ics [37, 38].
Hence, given the in vivo implications of CNTs corona, 
here we want to understand the factors that influence the 
protein coating of nanotubes. In this study, we take into 
account factors such as the properties of the surface of 
the nanotubes, the size of the nanotube, the temperature 
during functionalization, or the particularities of bio-
logical media, all critical aspects in nanobiotechnology. 
Finally, we develop a method to customize and control 
the CNTs corona with recombinant proteins designed 
and produced ad-hoc. This method also prevents nonspe-
cific protein biofouling and denaturation of the synthetic 
coating protein.
Results
Numerous studies show that CNTs capture a high num-
ber of proteins on their surfaces but few papers dem-
onstrate the morphological and mass implications of 
functionalization. As a first objective, we wanted to iden-
tify morphological changes on CNTs upon protein coat-
ing using transmission electron microscopy (TEM) and 
atomic force microscopy (AFM). Figure  1 shows TEM 
and AFM images of pristine MWCNTs before and after 
functionalization with serum proteins. Both TEM and 
AFM techniques reveal a significant enlargement of the 
diameter of the tubes.
To calculate the amount of protein adsorbed on this 
bio-coating, we functionalized different nanotubes, 
namely pristine SWCNTs (SWCNTs), pristine MWCNTs 
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(MWCNTs), and oxidized MWCNTs (o-MWCNTs) with 
bovine serum as a standard protein mixture (Materials 
and Methods), and performed a thermogravimetric anal-
ysis (TGA) in the presence of oxygen. Results shown in 
Fig. 2 demonstrate how, upon temperature rise, pristine 
(non-functionalized) SWCNTs displayed a single mass 
loss observed at approximately 600  ºC, corresponding 
to the combustion of carbon. In serum functionalized 
SWCNTs the loss of mass below 600 ºC corresponded to 
the combustion of organic matter. This mass reduction 
was observed in two steps, 200–400 ºC, and 400–600 ºC. 
Thus, the calculated loss of mass corresponding to bio-
molecules (mostly proteins) in functionalized SWCNTs 
corresponded to approximately 60% of the mass of the 
functionalized nanotubes.
Pristine MWCNTs displayed a single mass loss 
observed at ca. 550 ºC, corresponding to the combus-
tion of carbon. The same nanotubes functionalized with 
serum displayed a two-step mass reduction (two different 
slopes), at 250–400 ºC and 400–550 ºC as a result of the 
combustion of the organic matter. Here, the calculated 
mass of the biocorona approximately corresponded to 
30% of the functionalized MWCNTs weight.
Finally, the mass loss observed in non-functional-
ized o-MWCNTs occurred in two slopes. The first 
(100–550  ºC), corresponding to the oxidized groups 
(approximately 45%), and the second (from 550  ºC), 
corresponding to the combustion of carbon, starting at 
approximately the same temperature as in observed for 
pristine MWCNTs. This second mass loss corresponded 
to ca. 40% of the mass. Upon functionalization with pro-
teins, o-MWCNTs displayed an extra mass drop between 
temperatures 250–550 ºC that represented the total sum 
of the organic matter (serum proteins) added to the oxi-
dized group combustion. Taking into account that the 
loss of mass that corresponded to the oxidized groups was 
45%, the final calculated protein mass in functionalized 
o-MWCNTs was ca. 20% of the total weight of the bio-
functionalized o-MWCNTs. Summarizing, the percent-
age of mass that corresponded to the protein adsorbed 
on the surface of the CNTs depended on the size and 
properties of the nanotubes, and fluctuated between 20 
and 60% of the total mass of the functionalized CNTs, 
with SWCNTs capturing the highest amounts. These 
percentages confirmed that CNTs adsorbed enormous 
amounts of proteins, especially SWCNT (as represented 
in Fig.  2 diagram) and that in  vivo, this bio-camouflage 
will be pivotal in driving CNTs interactions with the dif-
ferent biological systems.
Our next step was to understand whether the quantita-
tive and qualitative composition of the corona was pre-
dictable or constant. To do this, we explored changes as a 
function of the CNT type, for it is known that the variety 
of proteins on the nanotube surface is strongly influenced 
by the diameter, the hydrophobicity, or functional groups 
on the surface of the CNTs [28]. For instance, oxidized 
nanotubes bind more variety of proteins than pristine 
nanotubes, and proteins that bind SWCNTs have a low 
affinity for MWCNTs [39]. But we would like to compare 
the proteins that bind to different nanotubes exposed to 
the same biological media -in this case, bovine serum- 
using an identical functionalization protocol.
To visually and straightforwardly evaluate these bio-
coatings -quantitatively and qualitatively -, we compare 
the different biochemical protein “landscapes” on func-
tionalized CNTs. To do this, the total protein on the sur-
face of the different functionalized CNTs was stripped 
with Laemmli buffer. The obtained protein solution was 
then loaded on SDS-PAGE gels for biochemical analysis 
and, upon electrophoresis, gel staining (Additional file 1: 
Fig. S3), scanning, and digital analysis, the protein “land-
scapes” were calculated. Hence these green profiles dis-
play a visual qualitative and quantitative representation 
of the protein distribution for each type of CNTs (Mate-
rials and Methods).
Fig. 1 Functionalized MWCNTs significantly increase their 
diameter upon functionalization with proteins. TEM and AFM 
images of identical MWCNTs before (left) and after (right) serum 
functionalization. A significant enlargement of the nanotube 
diameter is observed upon protein coating. The uneven staining of 
the functionalized CNTs in the TEM images suggests a discontinuous 
protein coating on the nanosurface
Page 4 of 13García‑Hevia et al. J Nanobiotechnol          (2021) 19:129 
As a first approach, we compared pristine and oxi-
dized MWCNTs (o-MWCNTs). These two types of 
nanotubes often fall into one category in nanobiotech-
nology/nanomedicine despite they are considered dif-
ferent from the physicochemical point of view. For the 
study, we used two varieties of nanotubes of each type 
-two types of o-MWCNTs, and two of pristine MWC-
NTs. The nanotubes were functionalized in the same 
bovine serum following identical protocols (Material 
and Methods). Interestingly, upon biochemical analysis, 
we found unique protein “landscapes” for each nanotube 
type. Figure 3 shows how proteins that are visible in one 
Fig. 2 Thermogravimetric analysis (TGA) of SWCNTs, pristine MWCNTs, and o‑MWCNTs. The calculated percentages of the final mass of the 
functionalized nanotubes corresponding to the biomolecular coatings are indicated in red
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of the o-MWCNTs types are not detected in the other 
oxidized nanotube (red arrows). Similarly, the two types 
of MWCNTs used in the study produced very different 
protein peaks in the landscapes (red arrows) which sug-
gests that small changes on the surface of the nanotube 
could be very critical in the interaction with environmen-
tal proteins.
Temperature is a key factor in protein folding and can 
significantly increase the flexibility and unfolding degree 
of polypeptides. Thus, the temperature at functionaliza-
tion could also have important implications in nano-
medicine since, depending on the preparation of the 
samples and their conservation, the in  vivo behavior of 
CNTs could vary significantly [29]. Because of this, the 
next factor that we have analyzed was the influence of 
temperature on the interaction of proteins with CNTs 
as a function of time. To do this, we incubated a single 
representative type of (pristine) MWCNTs with a single 
type of serum at 37 °C and 4 °C for different times. As in 
the previous section, we examined changes in the protein 
landscapes on the surfaces of the nanotubes using SDS-
PAGE analysis (Fig. 4, Additional file 1: Fig. S4). Figure 4 
shows how nanotubes incubated at 37 ºC displayed fewer 
proteins in the range of 60–50  kDa on their surfaces 
compared to the same nanotubes incubated with the 
same serum but at 4 ºC during 24 and 48 h (red arrows). 
Again, these studies show how, for a single type of CNT, 
temperature and time conditions are critical factors in 
the final composition of the corona.
These findings suggest there could be small tempera-
ture-triggered conformational changes of the proteins 
that could cause changes in the composition of the 
corona, as observed in previous studies [19, 28]. From 
a biochemical point of view, physiological temperatures 
close to 37  °C allow proteins to be more dynamic and 
more flexible, and this could result in greater polypep-
tidic interaction with the surface of the nanotube. Most 
proteins, and serum albumin, in particular, exhibit great 
structural plasticity at physiological temperature and 
their polypeptides can spread over the surface of the 
CNTs, unfolding slightly, covering a larger surface of the 
nanotube, thus interfering with the binding of other pro-
teins, more flexible or voluminous [29]. Interestingly, and 
as described for other types of nanomaterials [40], after 
72 h of incubation, the originally adsorbed proteins were 
progressively replaced by others with different affinities 
for the nano-surface. However, these differences in the 
biocorona formed at 4 or 37 °C did not result in clear dif-
ferences in the percentage of protein captured in the total 
mass of the functionalized nanotubes (see TGA in Addi-
tional file 1: Fig. S5).
Preceding literature details with high precision the 
great variety of proteins that bind to CNTs when exposed 
to human serum, plasma, or other biologically relevant 
fluids [17, 39, 41, 42]. Generally, studies agree that the 
most predominant proteins in these fluids, such as albu-
min, are present on the corona. However, each analysis 
lists a different list of proteins captured by the nanotubes. 
The different protein listings raise the question of what 
might happen if CNTs are exposed to sera from different 
human donors. Given our previous results, and to trans-
late their significance in the context of nanomedicine, we 
now questioned if the same type of CNTs would inter-
act with identical, or very similar, proteins upon expo-
sure to different human sera. To investigate this issue, 
we exposed a single type of CNT to 4 different healthy 
human sera with known compositions (Additional file 1: 
Table  S1). Interestingly, our results reveal that different 
sera interacted differently with the same type of CNTs. 
While some proteins do not appear on the surface of the 
nanotube and many changes their level of affinity (red/
blue arrows respectively, Fig. 5). This means that the same 
type of nanotube could behave completely differently in 
each patient depending on the peculiarities and proper-
ties of their serum. Thus, this finding has important bio-
medical implications, as it suggests that CNTs -as well as 
any other graphene-coated nanosystems [43–49], could 
have completely different effects in different patients.
Finally, to identify the protein landscape of the CNTs 
upon crossing the plasma membrane and binding intra-
cellular proteins, we functionalized pristine MWCNTs 
and o-MWCNTs with a cell extract containing a mix-
ture of intracellular proteins. To do this study, we chose 
human HeLa cells, a well-studied cervical carcinoma cell 
line in which CNTs have been shown to penetrate, trig-
gering antiproliferative and pro-apoptotic effects [37]. 
On this occasion, the nanotubes were functionalized in a 
suspension of cytoplasmic intracellular proteins obtained 
from HeLa cell culture lysates. Figure  6 shows the dis-
tinctive protein profiles for the two types of nanotubes 
upon incubation with intracellular proteins. As expected, 
these protein patterns were also different from those 
observed when the nanotubes were functionalized with 
either bovine or human sera (Additional file 1: Fig. S7).
These results led us to design a predictable protein 
coating for nanotubes, to prevent non-specific interac-
tion with the environmental proteins, a novel function-
alization system that could also serve to improve CNTs 
targeting while preventing the activation of the immune 
responses and premature elimination of the nanotubes. 
For this purpose, we used genetic engineering to design 
a synthetic (recombinant) protein containing a peptide 
targeting the Human Epidermal Growth Factor Recep-
tor 2 (HER2, also known as Neu or ErbB2). This recep-
tor is overexpressed on the surface of multiple tumor 
cell types including breast [50, 51], ovarian [52], lung 
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Fig. 3 Biochemical landscapes of o‑MWCNTs and MWCNTs functionalized with the same bovine serum. The qualitative and semi‑quantitative 
protein landscapes (green profiles) were calculated from the SDS‑PAGE protein analysis (in horizontal). These profiles demonstrate how identical 
protein components interact very differently with each nanotube. Arrows indicate some of the most divergent protein peaks. Molecular weights 
(MW) of the proteins are indicated at the bottom of the figure. The full SDS‑PAGE analysis is shown in Additional file 1: Figure S3
Fig. 4 Biochemical landscapes upon MWCNTs incubation with serum at 4 ºC or 37 ºC. The protein landscapes obtained upon MWCNTs incubation 
with bovine serum at 4 ºC or 37 ºC during 24, 48, and 72 h. SDS‑PAGE analysis reveals how the same protein components interact very differently 
with the same nanotube as a function of temperature and time. Arrows indicate some of the most divergent protein peaks. Molecular weights 
(MW) of the proteins are indicated at the bottom of the figure. The full SDS‑PAGE analysis is shown in Additional file 1: Figure S4
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[53], stomach, oral cancers [54] and, its relatively low 
expression on normal tissues makes it a clinically use-
ful molecular target for directed therapies. The syn-
thetic protein sequence designed contained: (i) a 
cationic CNT-binding peptide [55] in the N-terminus, 
(ii) a fluorescent reporting protein (GFP), and (iii) a the 
HER2-binding peptide [56] at the C-terminus (Fig. 7a). 
The CNT-binding domain consisted of a 10xHis cati-
onic peptide that can be attached to most proteins. This 
peptide is useful in protein affinity purification and pre-
vents recombinant protein direct interaction with the 
nanosurface of the CNTs, thus preventing ligand–pro-
tein denaturation. In this case, denaturation would be 
detected by protein fluorescence quenching. The syn-
thetic HER2-binding protein (HER2bp) was produced 
in bacteria and was purified using affinity chromatogra-
phy (Materials and Methods). Functionalization of the 
nanotubes was performed with saturating amounts of 
the HER2bp recombinant protein resuspended in PBS 
(Materials and Methods). Functionalized CNTs became 
fluorescent (Fig.  7b), thus indicating the recombinant 
GFP-fused protein was correctly folded (native) upon 
binding to the nanotube. This result is interesting in the 
context of preventing the activation of the immune sys-
tem resulting from the denaturalization (unfolding) of 
the CNT-interacting proteins [29].
To investigate if functionalization with this synthetic 
protein served to control the unwanted interaction of 
the nanotube surface with nonspecific proteins of the 
environment, we incubated HER2bp-functionalized 
CNTs with bovine serum for 16  h at 30 ºC. Figure  7c 
shows the landscapes of (i) the purified HER2bp pro-
tein, (ii) the protein stripped of the as-prepared 
HER2bp-CNTs, and (iii) that of the same HER2bp-
CNTs after incubation with serum. The obtained bio-
chemical landscapes demonstrate the efficiency of this 
functionalization method preventing protein dena-
turation and biofouling with unwanted environmental 
proteins (Additional file  1: Fig. S8). In summary, we 
demonstrate how the use of custom-made proteins, 
such as this HER2bp, can be a predictable way to func-
tionalized CNTs for biomedical purposes.
Discussion
The unpredictability of the biocorona composition 
makes it impossible to predict the fate and effects of 
CNTs in the in  vivo context. Here we show how the 
final protein assortment on the nanotubes depends on 
many factors, namely (i) the surrounding media, (ii) 
the temperature, (iii) the exposure time, (iv) the type of 
nanotube -concerning its size and reactivity-, and, more 
interestingly, the individuality of the human sera. Since 
all these factors are critical for in vivo applications, we 
have developed a way to predictably control the nano-
tube surface with synthetic proteins created and pro-
duced ad hoc. We have designed a cationic peptide to 
stably bind synthetic (recombinant) proteins to oxi-
dized nanotubes, and demonstrate that this attach-
ment protects the CNTs from unwanted interactions 
with the environmental proteins. Since these custom-
made CNT-binding proteins have a modular design, 
they can be designed ad-hoc according to the experi-
mental needs simply by changing the targeting moie-
ties, or fluorescent tags, to improve the predictability/
localization of CNTs in most biological environments. 
Besides, this design can also be used to functionalized 
two-dimensional graphene-based nanomaterials to cre-
ate unique nanostructures for biomedical applications. 
These important changes in the biocorona are a nota-
ble issue to consider in the in vivo context as the affini-
ties and surface charge of these nanomaterials change. 
These modifications are can cause a change in targeting 
and, consequently, in the toxicity and possible cumula-
tive effect of these carbonous nanomaterials [47, 48].
Conclusions
Understanding and controlling the biomolecular coating 
on CNTs is the first step in nanobiotechnology and nano-
medicine to be able to predict the biodistribution and 
effects of CNTs. This step is critical to producing reli-
able nanotherapies and nanovectors for in  vivo applica-
tions. The protein corona endows CNTs with a biological 
identity that enables their intermingling with local com-
ponents and participation in exquisite complementary 
molecular interactions [57]. These proteins determine 
the interaction of nanotubes with biological components, 
such as receptors, membranes, cytoskeletal filaments, 
etc., so understanding their variation and controlling 
their nature is essential in in vivo contexts. For this rea-
son, we have developed a genetic engineering method to 
produce a stable custom-designed biocorona on nano-
tubes that allows predetermining the nature of the CNTs, 




Pristine MWCNTs (NC3100™) and oxidized MWC-
NTs (o-MWCNTs) (NC3101™) were purchased from 
Nanocyl. Pristine SWCNTs (900,711) and MWCNTs 
(698,849) (where indicated) from Sigma-Aldrich as pow-
der. A characterization table is also provided (Additional 
file 1: Table S2). In-house o-MWCNTs were prepared as 
previously described [58, 59] using pristine MWCNTs 
(Nanocyl NC3100™) that were oxidized by sonication of 
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a mixture of  H2SO4/HNO3 (3:1) at 37  °C for 9  h under 
continuous shaking. o-MWCNTs were washed with a 
NaOH aqueous solution by three centrifugation/redisper-
sion cycles (13,000 rpm). The acid solution was removed 
by filtration through a 0.45 μm Teflon membrane and was 
washed in  H2O until pH ∼ 7.
CNTs characterization
CNTs were characterized by thermogravimetric analy-
sis, mass spectrometry, and FTIR in previous studies [60]. 
The unpolarized Raman spectra in Additional file  1: Fig. 
S1, S2 were taken with a Horiba T64000 triple spectrom-
eter in the backscattering geometry, using the 514.5  nm 
line of a Coherent Innova Spectrum 70C Ar + Kr + laser 
and a nitrogen-cooled CCD (Jobin–Yvon Symphony) with 
a confocal microscope for detection. The laser beam was 
focused down to 1 μm spot with a 100 × objective and kept 
the power on the sample below 2mW to avoid laser-heating 
effects on the probed material and the concomitant soften-
ing of the observed Raman peaks (Additional file 1: Fig. S1).
Serum functionalization
Functionalization of different CNTs was performed by 
nanomaterial dispersing in 30% serum protein solutions. 
CNTs were incubated at 37 ºC for 24 h unless otherwise 
indicated in the text. CNTs dispersions were washed by 
Fig. 5 Biochemical landscapes of MWCNTs functionalized with 4 different human sera. Biocorona protein profiles were obtained upon incubation 
of a single type of MWCNTs with 4 different healthy human sera during 24 h. The biochemical landscapes reveal how the protein components of 
human sera interact differently with the same nanotube. Arrows indicate some of the most divergent protein peaks. Some proteins are completely 
absent in some of the samples (blue arrows) while others display significant changes in their affinity for the nanotube (red arrows). Molecular 
weights (MW) of the proteins are indicated at the bottom of the figure. The full SDS‑PAGE analysis is shown in Additional file 1: Figure S6
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centrifugation for 2 min at 10,000g. Their concentration 
was determined by optical absorption at 550 nm using a 
calibration curve as previously described [61, 62]. Bovine 
serum (BS) was obtained from Gibco-Life Technologies 
(Cat No. 10108165). Human sera were collected from dif-
ferent donors at the Basque Center for Transfusion and 
Human Tissues (Additional file  1: Table  S1). Sera were 
obtained by repeated cycles of vortex mixing followed by 
mild sonication (cycles of 5″ on, 5″ off, 10 min, frequency 
of 38 kHz).
HeLa protein lysate preparation and functionalization
HeLa cells (ATCC® CCL-2) were cultured under stand-
ard conditions in Minimum Essential Medium contain-
ing 10% serum, and ampicillin (1:1000). Approximately 
 107 cells were harvested by trypsinization, washed with 
phosphate-buffered saline (PBS), and incubated in lysis 
buffer. The cells were broken by pipetting and the super-
natant was separated by centrifugation (13,000  rpm, 
5 min). HeLa cell-lysate supernatant proteins were mixed 
with 200  μg o-MWCNTs were sonicated (5  min, 2  s 
pulses, 65% amplitude, 4  °C), and were washed 3 times 
with PBS to remove the excess protein.
TEM, AFM, TGA 
TEM images were obtained on JEOL JEM-2100 oper-
ating at 80  kV. Samples for TEM were prepared using 
ethanol as a dispersant and a drop of this suspension 
was adsorbed onto a lacey copper grid. Protein on CNTs 
was stained with lead citrate and uranyl acetate. AFM 
was performed using a WITec alpha-300 microscope on 
nanotube samples dried on a borosilicate glass cover-
slip. TGA was carried out using a Setaram Setsys Evo-
lution 1700 apparatus, ranging from ca. 20–1000  °C. 
Measurements were performed under an air atmosphere 
with a heating rate of 10 °C  min−1 at a total flow rate of 
20 mL  min−1.
SDS–PAGE protein analysis
SDS-PAGE was performed on CNTs incubated with the 
protein solutions after repeated washed by centrifuga-
tion. All samples analyzed contained 30 µgr of functional-
ized CNTs. The nanotube concentration was determined 
by optical absorption as described previously [61]. Total 
protein on functionalized nanotubes was stripped with 
buffer Laemmli (0.125 M Tris–HCl pH 6.8, 20% glycerol, 
4% SDS, 2% mercaptoethanol, 0.02% bromophenol blue) 
Fig. 6 Biochemical landscapes of MWCNTs and o‑MWCNTs functionalized with human intracellular proteins. The two types of nanotubes interact 
differently with the intracellular proteins obtained from HeLa cells. The full SDS‑PAGE analysis including comparison with bovine and human serum 
proteins is shown in Additional file 1: Figure S7
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at 95 ºC for 10 min. The protein mixture was loaded on 
Mini-Protean® precast gels (BioRad) for SDS-PAGE anal-
ysis. The protein landscape analysis was obtained using 
Coomassie blue-stained gels that were scanned with a 
BioRad GelDoc EZ system. Protein patterning corre-
sponds to Bio-Rad molecular weight standards.
Gene synthesis, protein expression, purification, and CNT 
functionalization
The recombinant gene was synthesized (General Biosys-
tems) and was cloned in pET 15b plasmid systems (Nova-
gen). One Shot™ BL21(DE3) E. coli (Thermo Fisher) cells 
were transformed with the expression vector. The clone 
Fig. 7 Genetically engineered protein design to prevent non‑specific protein biofouling. a A recombinant protein design: CNT‑binding peptide 
(CNT‑bp) genetically attached to GFP and HER2 binding peptide. b Confocal microscopy image of fluorescent HER2bp‑functionalized CNTs. 
Fluorescence indicates the GFP in the protein is not denatured upon attachment. c Protein landscapes of the purified HER2bp (top); the protein 
stripped from the HER2bp functionalized nanotubes (middle lane), and the total protein stripped from the functionalized nanotubes after 
incubation with serum. The presence of a single band demonstrates how the synthetic protein prevents unwanted biofouling of serum proteins on 
the nanotube
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was cultured in LB broth medium, and when the opti-
cal density was 0.5 (590  nm) then Isopropylb-D thioga-
lactopyranoside (1.0  mM IPTG, PanReac AppliChem) 
was added. After 6  h at  room temperature incubation, 
cells were collected by centrifugation and were resus-
pended in LEW buffer (50  mM  NaH2PO4 and 300  mM 
NaCl in distilled water pH = 8.0). 1  mg/ml lysozyme 
and protease inhibitor (Pierce, Thermo Fischer) were 
added to lyses bacterial cells. Bacterial cell lysates were 
obtained by probe sonication (5 × 15  s pulses at 130 W, 
65% amplitude, with 15  s intervals, 4 ºC) and insoluble 
material synthesized by centrifugation. Bacterial soluble 
protein lysate was loaded onto pre-equilibrated Ni-TED 
columns (Protino®  Ni-TED, Macherey–Nagel GmbH & 
Co., Düren, Germany). Recombinant His-tagged protein 
was eluted in buffer supplemented with 250 mM imida-
zole. PD-10 Desalting Columns (GE Healthcare, Chicago, 
USA) were used to remove the imidazole and exchange 
buffer to PBS. Finally, saturating amounts of the recom-
binant protein were mixed with 200  μg o-MWCNTs, 
were sonicated (5 min, 2 s pulses, 65% amplitude, 4 °C), 
and were washed 3 times with PBS to remove the excess 
protein.
Confocal CNT imaging
Functionalized CNTs were placed on a coverslip 
and imaged using a Nikon A1R confocal microscope 
(100 × 1.46 n.a. lens).
Illustrations
Illustrations have been created with the BioRender soft-
ware available at BioRender.com.
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